Chargement en cours...
Boceprevir and personalized medicine in hepatitis C virus infection
Boceprevir was the first agent, along with telaprevir, of a novel class of direct-acting antivirals that entered clinical practice for the treatment of chronic hepatitis C. Boceprevir is an antiprotease that directly blocks hepatitis C virus (HCV) replication. Two studies in patients with HCV genoty...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3513234/ https://ncbi.nlm.nih.gov/pubmed/23226068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S24259 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|